JP2016524609A5 - - Google Patents

Download PDF

Info

Publication number
JP2016524609A5
JP2016524609A5 JP2016514430A JP2016514430A JP2016524609A5 JP 2016524609 A5 JP2016524609 A5 JP 2016524609A5 JP 2016514430 A JP2016514430 A JP 2016514430A JP 2016514430 A JP2016514430 A JP 2016514430A JP 2016524609 A5 JP2016524609 A5 JP 2016524609A5
Authority
JP
Japan
Prior art keywords
depression
composition
group
food
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2016514430A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016524609A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2014/060634 external-priority patent/WO2014187943A1/en
Publication of JP2016524609A publication Critical patent/JP2016524609A/ja
Publication of JP2016524609A5 publication Critical patent/JP2016524609A5/ja
Withdrawn legal-status Critical Current

Links

JP2016514430A 2013-05-24 2014-05-23 メントール及び/又はイシリンを用いるうつ病の処置又は予防 Withdrawn JP2016524609A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361827256P 2013-05-24 2013-05-24
US61/827,256 2013-05-24
PCT/EP2014/060634 WO2014187943A1 (en) 2013-05-24 2014-05-23 Treatment or prevention of depression using menthol and/or icilin

Publications (2)

Publication Number Publication Date
JP2016524609A JP2016524609A (ja) 2016-08-18
JP2016524609A5 true JP2016524609A5 (enExample) 2017-06-29

Family

ID=50841770

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016514430A Withdrawn JP2016524609A (ja) 2013-05-24 2014-05-23 メントール及び/又はイシリンを用いるうつ病の処置又は予防

Country Status (8)

Country Link
US (1) US20160108005A1 (enExample)
EP (1) EP3003294A1 (enExample)
JP (1) JP2016524609A (enExample)
CN (1) CN105263481A (enExample)
AU (1) AU2014270339A1 (enExample)
BR (1) BR112015028884A2 (enExample)
CA (1) CA2908378A1 (enExample)
WO (1) WO2014187943A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116076776A (zh) * 2022-12-19 2023-05-09 惠州市新泓威科技有限公司 具有抑制单胺氧化酶活性作用的电子烟雾化液
CN116158550A (zh) * 2022-12-19 2023-05-26 惠州市新泓威科技有限公司 具有抗抑郁作用的电子烟雾化液及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2651865C (en) * 2006-05-10 2015-11-24 Janssen Pharmaceutica N.V. Cold menthol receptor-1 antagonists
AU2008275927B8 (en) * 2007-07-18 2014-08-14 Janssen Pharmaceutica N.V. Sulfonamides as TRPM8 modulators
US8217060B2 (en) * 2009-05-15 2012-07-10 Janssen Pharmaceutica, Nv Benzimidazole derivatives useful as TRP M8 receptor modulators
JP6205133B2 (ja) * 2009-07-10 2017-09-27 プレジデント アンド フェローズ オブ ハーバード カレッジ 抗炎症剤としての恒久的に荷電したナトリウムおよびカルシウムチャンネルブロッカー
JP2012193176A (ja) * 2011-03-03 2012-10-11 Nippon Zoki Pharmaceut Co Ltd ミルナシプラン含有経皮吸収用医薬組成物
CN102258751A (zh) * 2011-07-21 2011-11-30 泰一和浦(北京)中医药研究院有限公司 用于治疗忧郁症、消愁解忧、善解抑郁的中药薄荷
JP5376481B1 (ja) * 2013-03-04 2013-12-25 日本臓器製薬株式会社 経皮吸収用医薬組成物

Similar Documents

Publication Publication Date Title
BR112017012299A2 (pt) modulação imunológica
BR112015023484A2 (pt) composição de carboidrato, produto e processso para preparar uma composição de carboidrato
BR112015017322A2 (pt) composição flavorizante e composições comestíveis contendo a mesma
BR112015011843B8 (pt) composição para promover a saúde intestinal
WO2019066577A3 (ko) 짧은 사슬 지방산 생성 장내 세균 군집의 변화를 이용한 알코올성 간 질환의 진단 및 치료용 조성물
NO20085374L (no) Anvendelse av fytat som middel for a inhibere opplosning av krystaller av kalsiumsalter for forhindring av osteoporose
EA201791531A1 (ru) Натуральный подсластитель
WO2019023039A3 (en) COMPOSITIONS FOR IMPROVING THE BIOAVAILABILITY OF PHARMACEUTICAL PRODUCTS, COMPLEMENTS AND INGREDIENTS
JP2016524608A5 (enExample)
JP2016536331A5 (enExample)
WO2016080796A3 (ko) 세스퀴테르펜 화합물을 포함하는, stat3 매개 질환의 예방 또는 치료용 약학적 조성물 및 이의 용도
TR201908639T4 (tr) Dejeneratif göz bozukluklarının önlenmesi ve veya tedavisine yönelik safran bazlı bileşimler.
CA3025425C (en) TABLETS WITH A HIGH CONTENT OF ACTIVE INGREDIENTS OF OMEGA-3 AMINO ACID SALTS
JP2016524609A5 (enExample)
WO2016190566A3 (ko) 아위버섯 물 추출물을 유효성분으로 함유하는 대사성질환의 예방 및 치료용 약학적 조성물 또는 건강기능성식품
WO2016076607A3 (ko) Compound k 성분이 강화된 홍삼농축액을 함유하는 비알코올성 지방간증의 예방 및 치료용 약제학적 조성물 및 건강기능 식품
WO2018078599A3 (en) Composition for the preventive or curative treatment of liver disorders
JP2016520588A5 (enExample)
BR112018016468A2 (pt) método de obtenção de uma forma solúvel de moléculas lipofílicas, composição, e, matéria-prima.
LT4081502T (lt) Ketoprofeno kokristalas ir jo gamybos būdas, jį apimančios farmacinės kompozicijos ir jų panaudojimo būdai
BR112017013886A2 (pt) produto para fornecimento por via oral
LT3764992T (lt) Farmacijos produkto arba maisto papildo preparatas alfalaktalbumino pagrindu
WO2015127320A3 (en) Single serve beverage compositions
WO2016072692A3 (ko) 네크록스를 유효성분으로 함유하는 점막염 예방 또는 치료용 조성물
WO2016007871A3 (en) Immune motifs in products from domestic animals